Td Asset Management Inc Rocket Pharmaceuticals, Inc. Transaction History

Td Asset Management Inc

$106 Billion
Q4 2024

A detailed history of Td Asset Management Inc transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 178,454 shares of RCKT stock, worth $1.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

178,454

Previous 177,610 0.48%

Holding current value

$1.64 Million

Previous $3.28 Million 31.62%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$11.35 - $18.82 $9,579 - $15,884	844 Added 0.48%	178,454 $2.24 Million
Q3 2024 Nov 01, 2024	SELL	$17.6 - $25.88 $9,750 - $14,337	-554 Reduced 0.31%	177,610 $3.28 Million
Q2 2024 Aug 02, 2024	BUY	$20.66 - $26.72 $475,180 - $614,560	23,000 Added 14.82%	178,164 $3.84 Million
Q1 2024 May 08, 2024	BUY	$26.16 - $30.74 $7,848 - $9,222	300 Added 0.19%	155,164 $4.18 Million
Q4 2023 Feb 12, 2024	BUY	$16.78 - $31.94 $718,754 - $1.37 Million	42,834 Added 38.23%	154,864 $4.64 Million
Q3 2023 Oct 27, 2023	BUY	$15.07 - $24.05 $844,146 - $1.35 Million	56,015 Added 100.0%	112,030 $2.3 Million
Q2 2023 Aug 09, 2023	BUY	$16.59 - $23.6 $267,099 - $379,960	16,100 Added 40.34%	56,015 $1.11 Million
Q1 2023 May 10, 2023	SELL	$15.79 - $22.6 $36,317 - $51,980	-2,300 Reduced 5.45%	39,915 $683,000
Q4 2022 Feb 06, 2023	BUY	$15.5 - $22.76 $140,476 - $206,273	9,063 Added 27.34%	42,215 $826,000
Q3 2022 Nov 07, 2022	SELL	$12.37 - $18.41 $408,593 - $608,100	-33,031 Reduced 49.91%	33,152 $465,000
Q4 2021 Feb 10, 2022	SELL	$21.52 - $36.02 $359,384 - $601,534	-16,700 Reduced 20.15%	66,183 $1.45 Million
Q2 2021 Aug 11, 2021	SELL	$39.41 - $47.25 $238,430 - $285,862	-6,050 Reduced 6.8%	82,883 $2.97 Million
Q1 2021 May 14, 2021	BUY	$43.34 - $65.91 $412,120 - $626,738	9,509 Added 11.97%	88,933 $3.95 Million
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $404,511 - $1.03 Million	17,361 Added 27.97%	79,424 $4.36 Million
Q3 2020 Nov 10, 2020	BUY	$20.5 - $28.59 $468,589 - $653,510	22,858 Added 58.3%	62,063 $1.42 Million
Q1 2020 May 15, 2020	SELL	$9.71 - $25.11 $90,303 - $233,523	-9,300 Reduced 19.17%	39,205 $547,000
Q4 2019 Feb 11, 2020	BUY	$11.07 - $24.23 $123,685 - $270,721	11,173 Added 29.93%	48,505 $1.1 Million
Q3 2019 Nov 07, 2019	BUY	$10.85 - $14.78 $88,850 - $121,033	8,189 Added 28.1%	37,332 $435,000
Q2 2019 Aug 01, 2019	BUY	$15.0 - $19.81 $77,700 - $102,615	5,180 Added 21.62%	29,143 $437,000
Q1 2019 May 08, 2019	SELL	$13.45 - $19.01 $17,485 - $24,713	-1,300 Reduced 5.15%	23,963 $420,000
Q4 2018 Feb 01, 2019	BUY	$11.21 - $23.53 $53,449 - $112,191	4,768 Added 23.26%	25,263 $374,000
Q2 2018 Jul 31, 2018	BUY	$14.58 - $23.0 $4,374 - $6,900	300 Added 1.49%	20,495 $402,000
Q1 2018 May 11, 2018	BUY	$11.68 - $19.19 $235,877 - $387,542	20,195 New	20,195 $379,000

Others Institutions Holding RCKT

# of Institutions

244

Shares Held

108M

Call Options Held

262K

Put Options Held

159K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $697M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Rocket Pharmaceuticals, Inc. Transaction History